Locations
Burlingame, CA, USA · Sunnyvale, CA, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health
Size
51-200 employees
Stage
Series C+
founded in
2016
Inflammatix is a molecular diagnostics company focused on developing rapid tests that interpret the immune response to diagnose acute infections and sepsis. Their innovative approach leverages bioinformatics, machine learning, and molecular biology to create tests that provide critical insights for emergency medicine physicians, addressing a significant unmet need in the healthcare system. With a pipeline that includes the Tri Verity test, Inflammatix aims to enhance patient outcomes and streamline clinical decision-making in emergency departments, where accurate and timely diagnosis is crucial. The company is positioned to transform the landscape of diagnostics for infectious diseases, with a strong emphasis on precision medicine and a commitment to improving healthcare delivery.
Something looks off?On-site & Remote